An autopsy case that manifested no convincing histological changes of severe renal failure after hematopoietic stem cell transplantation

CEN Case Reports
Kosuke HondaHisashi Sakamaki

Abstract

A 48-year-old Japanese woman, who had been diagnosed with smoldering adult T-cell leukemia, was admitted to our hospital for hematopoietic stem cell transplantation (HSCT) because of an acute exacerbation of her disease. After myeloablative conditioning procedures, comprising cytarabine with cyclophosphamide and total body irradiation, the HLA-matched unrelated bone marrow stem cells were infused (day 0). Her serum creatinine concentration, having been 0.6 mg/dL at baseline, began to increase from day 1 and was 2.3 mg/L on day 7. Hemodialysis was required to treat fluid overload and worsening uremia on days 8 and 9. On day 10, she presented with refractory hypotension and died due to multi-organ failure on day 12. Renal pathology at autopsy showed no specific histological changes to which her clinically severe acute kidney injury (AKI) was attributable. This case suggests that post-HSCT AKI is not necessarily accompanied by apparent renal histologic damage, even if it is clinically serious.

References

Mar 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R A ZagerE D Thomas
Apr 5, 1995·Journal of the National Cancer Institute·L B TravisJ Adami
Nov 1, 1994·Kidney International·R A Zager
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Joseph V Bonventre, Joel M Weinberg
Dec 4, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Somaya El-SeisiStephen Couban
Dec 22, 2004·Kidney International·Sangeeta R HingoraniGeorge B McDonald
Mar 3, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Robert W Schrier, Chirag R Parikh
Mar 9, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Chirag R ParikhBrenda M Sandmaier
Jan 6, 2006·Kidney International·C R Parikh, S G Coca
May 16, 2006·Critical Care : the Official Journal of the Critical Care Forum·Eric A J HosteJohn A Kellum
May 26, 2006·Journal of the American Society of Nephrology : JASN·Sangeeta Hingorani
Feb 1, 2008·Journal of the American Society of Nephrology : JASN·Seymour Rosen, Isaac E Stillman
Feb 16, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Chirag R ParikhBrenda Sandmaier
Mar 8, 2008·Critical Care : the Official Journal of the Critical Care Forum·Christoph LangenbergRinaldo Bellomo

❮ Previous
Next ❯

Citations

Aug 25, 2015·Bone Marrow Transplantation·N ShingaiM Ando

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.